Studying Unexpected Worsening of Tuberculosis During Treatment in Adults
Studies adults with tuberculosis who suddenly get worse while on treatment.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the siteAlso in 1 other country, 2 sites
- Trial code
- Registry title
- Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 20 Dec 2019
- Expected to end
- 30 Apr 2029
- Type of study
- Observational, 2 groups
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with confirmed or suspected TB, either with signs of a paradoxical reaction to TB treatment or as a comparison group.
- Age
- 18 years and older
- Sex
- All sexes can join
- Disease stage
- Confirmed or suspected TB. One group has at least 2 signs of a paradoxical inflammatory reaction, such as symptoms coming back after first getting better. The comparison group starts 2 to 4 months after beginning TB treatment.
- Earlier treatment
- The reaction group is on anti-TB treatment for at least 2 weeks, or has finished it. The comparison group presents 2 to 4 months after starting anti-TB treatment.
- Biomarker or test result
- Signs of reaction can include white blood cell count above 10,000 cells/microL or a change in C-reactive protein of more than 5 mg/L.
Main reasons for not taking part
- HIV infection
- Pregnant or breastfeeding
- Uncontrolled psychiatric disease or substance use
- Cancer needing imminent or ongoing radiation, chemotherapy or immunotherapy
- Urgent medical conditions not due to TB that need immediate treatment
The registry criteria, word for word
Show all 20 criteriaShow less
Who cannot take part
- HIV infection. (Individuals with HIV infection may be eligible for a separate study exclusively evaluating persons living with HIV.)
- Uncontrolled psychiatric disease, substance use, or inappropriate conduct unsuitable for a research study
- Malignancy requiring imminent or ongoing treatment including radiation, chemotherapy, or immunotherapy
- Debilitating or chronic conditions that would limit ability to participate in the study
- Emergent or urgent clinical conditions not due to studied disease of interest requiring immediate treatment that would be unsuitable for a research study. These patients would be transferred to an emergency room and able to rescreen when condition has been stabilized
- Individuals in either group who meet any of the following criteria will be excluded from study participation:
- Pregnant or breastfeeding
Other criteria
- INCLUSION CRITERIA:; Suspected Paradoxical Reaction Group Criteria:
- Aged greater than or equal to 18 years
- Diagnosed with confirmed (microbiologically or with molecular methods) or suspected (clinical plus or minus histologic diagnosis) TB and currently on ATT for a minimum of 2 weeks, or have completed ATT, with at least 2 of the following signs/symptoms of a paradoxical inflammatory reaction:; Recrudescent symptoms of TB after initial clinical improvement; Change in physical exam after initial clinical improvement suggestive of new inflammatory process (e.g., lymphadenopathy or new findings on pulmonary exam); Worsening radiographic evidence of disease after initiation of treatment, as compared with imaging prior to or earlier in treatment; Laboratory evidence of acute inflammatory response, including the development of leukocytosis (white blood cell count > 10,000 cells/microL) or a change of C-reactive protein (CRP) > 5 mg/L compared to prior laboratory values; Worsened organ function after initial clinical improvement
- The above sign/symptom(s) cannot be explained by a newly acquired infection, clinical course of a previously recognized infectious agent, side effects of the ATT, the presence of drug resistance, or any other condition except for paradoxical reaction
- Willingness to allow storage of blood or tissue samples for future research
- Ability of participant to understand study requirements and give informed consent
- Has a primary care physician and is being followed by the local Department of Health for their TB (or has plans to arrange after enrollment if enrolled early in course from inpatient transfer); Control Group Criteria:
- Aged greater than or equal to 18 years
- Diagnosed with confirmed (microbiologically or with molecular methods) or suspected (clinical plus or minus histologic diagnosis) TB
- Presenting 2 to 4 months after starting ATT to match timing of paradoxical reactions
- Willingness to allow storage of blood or tissue samples for future research
- Ability of participant to understand study requirements and give informed consent
- Has a primary care physician and is being followed by the Department of Health for their TB (or has plans to arrange after enrollment if enrolled early in course from inpatient transfer)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Where in United States
Also in 1 other country, 2 sites
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Mary E McLaughlin, R.N.Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Most people with tuberculosis (TB) feel better after starting treatment. But for some people, the opposite happens. They may feel better at first, but then suddenly get worse. This is a paradoxical reaction. Researchers want to better understand what causes this reaction and what happens after someone has it.
Objective:
To learn about paradoxical reactions to TB treatment.
Eligibility:
Adults 18 and older diagnosed with confirmed or suspected TB and currently on treatment for at least 2 weeks, with or without signs/symptoms of a paradoxical inflammatory reaction.
Design:
Participants will be screened with a physical exam and medical history. They will give blood and urine samples.
Eligible participants will visit either the NIH Clinical Center or the Mexico Clinic sites 3 times over 6 to 18 months. Each visit will take 7 hours to complete; visits may be scheduled over more than 1 day. Participants may have more visits if their TB symptoms change.
Participants will give blood, urine, and sputum samples. They will have adverse event assessments. They will have 2 to 3 positron emission tomography/computed tomography (PET/CT) scans. PET/CT scans make pictures of the inside of the body. For this, participants will lie on a table that slides into a donut-shaped scanner. They will get a small amount of radioactive dye through an IV, which is a small plastic tube placed in a vein in the arm using a needle.
Participants may have optional apheresis at the NIH site only. For this, blood is taken from a needle in one arm. White blood cells are separated from the rest of the blood. The rest of the blood is returned through a needle in the other arm.
The 2 groups in the trial
- 1
Patients with TB who have already initiated treatment and are suspected to have paradoxical reactions
- 2
Patients with TB who have already initiated treatment without signs of paradoxical reactions (control)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
- Plain-language title
- Studying Unexpected Worsening of Tuberculosis During Treatment in AdultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04052022, who can take part
- Record updated
- 2 November 2026